Skip to main content
profile image
Selected Works of Walter J. Urba, MD, PhD
Article
Results From an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
Clinical Cancer Research (2017)
  • Neil H Segal, Memorial Sloan Kettering Cancer Center
  • Theodore F Logan, Indiana University
  • F. Stephen Hodi, Harvard University
  • David F. McDermott, Harvard University
  • Ignacio Melero, University of Navarra
  • Omid Hamid, University of Sydney
  • Henrik Schmidt, Aarhus University
  • Caroline Robert, University of Paris-Sud
  • Vanna Chiarion-Sileni
  • Paolo A Ascierto, National Institutes of Health
  • Michele Maio, University of Siena
  • Walter J. Urba, Providence Portland Medical Center
  • Tara C Gangadhar, University of Pennsylvania
  • Satyendra Suryawanshi, Bristol-Myers Squibb
  • Jaclyn Neely, Bristol-Myers Squibb
  • Maria Jure-Kunkel, Bristol-Myers Squibb
  • Suba Krishnan, Bristol-Myers Squibb
  • Holbrook E. Kohrt, Stanford University
  • Mario Sznol, Yale University
  • Ronald Levy, Stanford University
Link
Disciplines
Publication Date
April 15, 2017
DOI
10.1158/1078-0432.CCR-16-1272
Citation Information
Neil H Segal, Theodore F Logan, F. Stephen Hodi, David F. McDermott, et al.. "Results From an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody" Clinical Cancer Research Vol. 23 Iss. 8 (2017) p. 1929 - 1936
Available at: http://works.bepress.com/walter-urba/98/